Real-World Experience in Treatment of Patients with Non-Small-Cell Lung Cancer with BRAF or cMET Exon 14 Skipping Mutations

BRAF and cMET exon 14 skipping are rare mutations of NSCLC. The treatment sequence in these cases for the first and second line is not clear. An international registry was created for patients with advanced NSCLC harboring BRAF or cMET exon 14 skipping mutations, diagnosed from January 2017 to June...

Descripción completa

Detalles Bibliográficos
Autores principales: Janzic, Urska, Shalata, Walid, Szymczak, Katarzyna, Dziadziuszko, Rafał, Jakopovic, Marko, Mountzios, Giannis, Płużański, Adam, Araujo, Antonio, Charpidou, Andriani, Agbarya, Abed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454089/
https://www.ncbi.nlm.nih.gov/pubmed/37629023
http://dx.doi.org/10.3390/ijms241612840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454089/
https://www.ncbi.nlm.nih.gov/pubmed/37629023
http://dx.doi.org/10.3390/ijms241612840

Ejemplares similares